Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic
solution, 1% on signs & symptoms of blepharitis and tear cytokine and eyelid bacterial load
levels